Oh man ! I hope the lefties don't get voted in

A New Frontier in Banking Truist is out here flipping the script in digital banking, pushing a staggering 2 billion AI-driven insights since 2023. Imagine that—two billion insights 'till now, providing the kind of financial street smarts that help folks feel less like they're lost at sea and more like they're the captain of their own financial ship, all thanks to Truist...

Action Time for Photronics Investors There's nothing like a looming deadline to get the adrenaline pumping, especially when you're staring down the barrel of a federal securities class action. Photronics, Inc. (NASDAQ: PLAB) has found itself tangled in legal webs, with the clock ticking down to September 4, 2026. That’s the deadline for investors to move on being the...

The Grit Behind Jan Pancar's Victory Now, tell me this isn’t a story that'll light a fire under anyone chasing an underdog tale. Jan Pancar, a rider marching to the beat of his own moto tune, just snagged the 2026 Italian Prestige 24MX MX1 title. Here’s the kicker: he did it racing for the family-led TEM JP253 KTM Racing Team, not some big-money factory squad. Triumph...

Changing the Game in Power Generation In the ever-shifting landscape of power generation, having a seasoned player at the helm can be the difference between stagnation and growth. FirstEnergy Corp. (NYSE:FE) has tapped Jon Dormo as its Vice President of Generation Project Development. The mission? Overhaul and expand projects to meet the increasing demands for...

Untangling the Mess Behind Game Day Ever wonder why getting to your seat at a sports event feels seamless? It's like magic with your ticket appearing as a barcode on your phone, the concession stand knowing your order from last week's game, and sponsor ads personalized just for you. This is no easy feat. Behind the scenes, though, it's akin to a game of Twister. The...

An Unexpected Invitation to the Elite Table You'd think a community bank from Oklahoma crashing a party of international finance heavyweights sounds odd, but that's exactly how the G20 threw down this year. Holding the reins, the U.S. took a swing at something different. Secretary of the Treasury Scott Bessent rolled out the red carpet for private-sector leaders,...

Shell’s Strategic Play: Snagging ARC When it comes to Shell, they don't dawdle with peanuts. Snagging ARC Resources Ltd., a Canadian energy firm rooted squarely in British Columbia and Alberta, speaks volumes about their appetite for growth. They’re shelling out approximately US$16.5 billion to pull this deal off the ground. This isn't just some casual sector play; it...

Navigating the SQL Server and Kubernetes Combo Well, if anyone tells you managing SQL Servers is a breeze, hand them a screwdriver and watch things turn. Combine that with Kubernetes, and you might just see some heads spinning. Dive into the world of SQL Server management on containers with the help of this webinar from MSSQLTips, DH2i, and Microsoft. It promises to...

Quick and Unexpected Moves at Mega Matrix Just when you thought things couldn't get more complicated in the world of Mega Matrix Inc. (NYSE: MPU), they pull a rabbit out of the hat at their Extraordinary General Meeting on September 1st. Held at their office in Singapore, shareholders green-lighted some heavy-hitting changes like a share consolidation—twenty into one...

Sometimes, it's not just about playing the game, but knowing which card to play. US Strategic Metals (USSM) and Ionic Rare Earths USA just unveiled a strategic move that’s likely to shake things up in the wild world of rare earths. As the partnership gears up to build a magnet recycling facility in Missouri, there’s chatter around creating a sustainable supply chain...

Overview of MoonLake Immunotherapeutics Class Action Investors in MoonLake Immunotherapeutics (NASDAQ: MLTX) have recently found themselves facing significant challenges. The disclosures regarding the company’s operations and the marketing of its products have prompted questions about the integrity of the information provided to shareholders. Why a Class Action? In a...

BioCryst Concludes Successful Sale of European ORLADEYO Business In a significant move, BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has confirmed the successful sale of its European ORLADEYO business to Neopharmed Gentili. This transaction is valued at $250 million and includes the potential for up to $14 million in future milestones linked to sales across Central and...

Overview of Investor Rights in the Edwards Lifesciences Case In today's financial landscape, safeguarding your investments is paramount. Edwards Lifesciences Corporation (NYSE: EW) has emerged as a notable player in the healthcare sector, particularly in innovative heart valve therapies. However, recent events have raised concerns among shareholders, prompting calls for...

Revolutionizing Radiotherapy with Accuray Stellar Accuray, a leader in adaptive radiotherapy, has launched the Accuray Stellar™ Solution, which is designed to transform cancer care. This innovative solution offers an expansive toolbox that empowers clinical teams to adapt treatments to fit each patient's unique needs. Accuray's commitment to enhancing radiotherapy...

Scale Computing Shines on Prestigious AI 100 Awards List Scale Computing, the market leader in edge computing and hyperconverged solutions, has recently made waves in the tech industry by being recognized on the annual CRN AI 100 list. This list marks a milestone as it celebrates companies that are at the forefront of innovation in artificial intelligence. Understanding...